BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4039838)

  • 1. [Do androgens have a therapeutic role in hematology?].
    Delwiche F; Velu T
    Rev Med Brux; 1985 Apr; 6(4):277-9. PubMed ID: 4039838
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploiting sex for therapeutic purposes.
    Gelfand JA
    N Engl J Med; 1983 Jun; 308(23):1417-9. PubMed ID: 6682485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Androgens in hematology].
    Sanchez-Medal L
    Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of androgens in the treatment of hematologic disorders.
    Ammus SS
    Adv Intern Med; 1989; 34():191-208. PubMed ID: 2644756
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions.
    Besa EC
    Semin Hematol; 1994 Apr; 31(2):134-45. PubMed ID: 8066470
    [No Abstract]   [Full Text] [Related]  

  • 6. Danazol in hemophilia.
    Ambriz R; Pizzuto J; Guillen C
    JAMA; 1985 Aug; 254(6):754-5. PubMed ID: 4009909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunodepressive agents in hematology].
    Sanchez-Fayos J; Outeiriño J; Serrano J; Calabuig MT; Paniagua G
    Cah Med; 1970 May; 11(5):433-43. PubMed ID: 5463876
    [No Abstract]   [Full Text] [Related]  

  • 8. [Betamethasone phosphate in hematology].
    Bauters F
    Lille Med; 1971 Apr; 16():S 2:625-30. PubMed ID: 5293269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Androgens in hematology].
    Sanchez-Medal L
    Cah Med; 1971 May; 12(7):515-22. PubMed ID: 5562270
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of androgens in hematologic disease.
    Fried W
    Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723
    [No Abstract]   [Full Text] [Related]  

  • 11. Danazol for severe disease.
    Marwick C
    JAMA; 1983 Jun; 249(24):3279, 3283. PubMed ID: 6854854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Androgen treatment of hematologic diseases].
    Huang ZL
    Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):239-42. PubMed ID: 2226054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppression in hematologic diseases].
    Bogdanikowa B
    Postepy Hig Med Dosw; 1975; 29(5):557-67. PubMed ID: 1239015
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of danazol in hematologic disorders.
    Ahn YS
    Acta Haematol; 1990; 84(3):122-9. PubMed ID: 2123061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive agents in hematology].
    Sánchez-Fayos J
    Munch Med Wochenschr; 1970 Mar; 112(12):530-6. PubMed ID: 4315918
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hematologic diseases using androgens].
    Sánchez-Medal L
    Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of the induction of cycling of erythropoietin sensitive cells by androgens and their 5 beta-H-metabolites.
    Jepson JH; Leonard RA; Gorshein D; Gardner FH; Besa E
    Biomedicine; 1974 Jul; 21(7):262-6. PubMed ID: 4611514
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successive problems of the surgical treatment of blood system diseases].
    Grozdov DM
    Probl Gematol Pereliv Krovi; 1966 Dec; 11(12):3-11. PubMed ID: 4878502
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiologic mechanisms and the hematopoietic effects of the androstanes and their derivatives.
    Gardner FH; Besa EC
    Curr Top Hematol; 1983; 4():123-95. PubMed ID: 6352190
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of danazol on idiopathic thrombocytopenic purpura].
    Suzuki H; Kojima T; Sano M; Saito H; Kawamoto M
    Rinsho Ketsueki; 1985 May; 26(5):709-16. PubMed ID: 4057585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.